Member Info for Laura2022

Taken some after watching the carnage

Also apparently Elon Musk in line to buy SND , see the info on that board

Thanks for your summary

With the current market capitalisation about £4mln and potential revenues of $200mln it would have to be higher than 10pence that ROX is offering

Takeover possible as you suggested last week then ?

Surely they have to give some clarity before the weekend it over ?

Apologies wrong group

This was posted on Telegram yesterday

It is emerging that Neuralink could be one of the

interested parties circling  embattled British chip maker Sondrel. Recently it is believed  that Sondrel solved some of Neuralink problems with their recent human brain implant which other chip suppliers could not solve. Neuralink Corp. is an American neurotechnology company that is developing implantable brain–computer interfaces, based in  California and  founded by Elon Musk and a team of scientists and engineers.

Neuralink had recently livestreamed its first patient implanted with a chip playing online chess.

By way of context, Sondrel is one of only  a handful of firms capable of supplying the higher-spec chips required, others are in Asia but are  considered vulnerable to Chinese interference

Values seeker

This was posted on Telegram yesterday

It is emerging that Neuralink could be one of the

interested parties circling  embattled British chip maker Sondrel. Recently it is believed  that Sondrel solved some of Neuralink problems with their recent human brain implant which other chip suppliers could not solve. Neuralink Corp. is an American neurotechnology company that is developing implantable brain–computer interfaces, based in  California and  founded by Elon Musk and a team of scientists and engineers.

Neuralink had recently livestreamed its first patient implanted with a chip playing online chess.

By way of context, Sondrel is one of only  a handful of firms capable of supplying the higher-spec chips required, others are in Asia but are  considered vulnerable to Chinese interference.

Evidence-based interventions, such as improved early detection and education programmes, will help to save lives and prevent ill health from prostate cancer in the years to come,” added James, a professor of prostate cancer research at the Institute of Cancer Research, London, and a consultant clinical oncologist at the Royal Marsden NHS foundation trust.

James said there was a global need for new and improved ways to test for the disease, to reduce overdiagnosis and overtreatment while detecting potentially lethal tumours earlier

This brings PYC technology well into focus

https://www.theguardian.com/society/2024/apr/04/prostate-cancer-cases-worldwide-diagnoses-deaths-2040-study

Nice summary again,really nice to have mew ideas / points of view

I assume that's why he's given 6mths before the GM

There was 15% of the shares in issue traded pn Tuesday but only one TR1 and that was relating to the trades pre Easter

Someone is buying in blocks for the last 3 days

Great Post sorcerer

That s an error ..up 100% over last 2 days

Sorry

Acceptance from NICE for one of their technology tests via RNS yesterday

Shows what could happen with our precision dosing app

Is an absolute ambulance chaser

Well done

Great to see life science companies doing well

PYÇ at £2mln cap well worth a look

Nice one

You've read the RNS I assume...you keep ambulance chasing and see you in a couple of weeks when SND has done a move of 50%+

Ant

I have only just noticed that this 50% increase In pipeline is excluding biostatistics work ....(Pete said in results there will be an update before June)

Company's pipeline of potential new business now stands at over £1.5m (not risk weighted and EXCLUDING Biostatistics), counting only opportunities where a specific project has been discussed with a client